These authors contributed equally to this work.
Version of Record online: 2 JUL 2012
Copyright © 2012 American Association for the Study of Liver Diseases
Volume 56, Issue 2, pages 444–454, August 2012
How to Cite
Naggie, S., Osinusi, A., Katsounas, A., Lempicki, R., Herrmann, E., Thompson, A. J., Clark, P. J., Patel, K., Muir, A. J., McHutchison, J. G., Schlaak, J. F., Trippler, M., Shivakumar, B., Masur, H., Polis, M. A. and Kottilil, S. (2012), Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-unfavorable genotype patients: Impaired viral kinetics and therapeutic response. Hepatology, 56: 444–454. doi: 10.1002/hep.25647
Potential conflict of interest: Eva Herrmann serves as a research consultant for Gilead Sciences, Roche Pharma, and Novartis. John McHutchison and Alex Thompson are coinvestigators on the IL28B rs12979860 patent.
Supported in whole or in part by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Cancer Institute, National Institutes of Health, under contract no. HSN261200800001E.
The content of this publication does not necessarily reflect the views of policies of the Department of Health and Human Services, nor does the mention of trade names, commercial products, or organizations imply endorsement by the United States government.
- Issue online: 25 JUL 2012
- Version of Record online: 2 JUL 2012
- Accepted manuscript online: 13 FEB 2012 06:38AM EST
- Manuscript Accepted: 28 JAN 2012
- Manuscript Received: 4 MAY 2011